share_log

SLANG Worldwide Announces First Quarter 2024 Financial Results

SLANG Worldwide Announces First Quarter 2024 Financial Results

SLANG Worldwide公布2024年第一季度财务业绩
newsfile ·  05/30 07:30

Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - SLANG Worldwide Inc. (CNSX: SLNG) (OTCQB: SLGWF) ("SLANG" or the "Company"), a leading global cannabis consumer packaged goods (CPG) company with a diversified portfolio of popular brands, today released financial results for the three months ended March 31, 2024. All figures in this press release are stated in Canadian dollars unless otherwise noted.

多伦多安大略省——(新闻稿:Newsfile corp. - 2024年5月30日)-SLANG Worldwide Inc.( CNSX:SLNG) (OTCQB:SLGWF) (简称"SLANG" 或 "公司"), 一家主流大麻消费品(CPG)公司,在多样化的品牌组合中拥有众多主流品牌,今天发布了2024年3月31日结束的三个月的财务报表。本新闻稿中的所有数据均以加元( CAD) 为单位。

"Our results for the first quarter demonstrated the importance of SLANG's diversified strategy as well as our commitment to our disciplined, efficient business model," commented John Moynan, Chief Executive Officer of SLANG. "While we saw softness in our Core Markets in the first quarter, we mitigated the impact on our business with increased sales in our newer, higher-margin e-commerce channel, our Vermont wholesale channel and across our Emerging Markets, and by reducing operating expenses sequentially and year-over-year, driving operational efficiencies across most segments of our business.

"我们第一季度的业绩表明了SLANG多样化策略的重要性,以及我们对我们的纪律、高效的商业模式的承诺," SLANG的首席执行官约翰·莫伊南这样说道。"虽然我们在第一季度的核心市场出现了一定的软弱,但我们在新兴市场、维吉尼亚州的销售渠道、以及大多数业务细分领域的控制营运费用方面,减少了年复合和环比营业费用的影响。"

"During the quarter, our new channels continued to increase their contribution to our overall sales. Revenue from our e-commerce business segment increased by approximately 45%, demonstrating the strength of our Alchemy Naturals CBD gummy product line, and our Vermont wholesale sales channel increased by approximately 417% year-over-year. Looking ahead, we believe we will continue to elevate our market position and build our leadership position in these important cannabis product categories."

"在这个季度,我们的新渠道继续增加对我们整体销售的贡献。我们的电子商务业务的收入约增长了45%,这证明了我们的Alchemy Naturals CBD水果糖产品线的实力,我们的维吉尼亚州批发销售渠道的销售额同比增长了约417%。展望未来,我们相信我们将继续提升我们的市场地位,并在这些重要的大麻产品领域打造我们的领导地位。"

Moynan continued, "I also want to highlight the recently announced recommendation by the U.S. Department of Justice that cannabis be rescheduled from Schedule I to Schedule III. We are hopeful that the recommendation for rescheduling will be successful and are looking forward to it being finalized as we believe that the rescheduling of cannabis will have a positive impact not just on SLANG but on the industry as a whole."

莫伊南继续说道,"我还想强调的是,美国司法部最近发布的有关将大麻从一级药物重新列入三级药物的建议。我们希望这种重新编排的建议能够成功,并期待它的最终定稿,因为我们相信大麻的重新编排不仅对SLANG,而且对整个行业都将产生积极的影响。"

First Quarter 2024 Financial Summary

第一季度2024年财务摘要

  • Revenue for the three months ended March 31, 2024, was $7.03 million. Declines in SLANG's Core Markets in Vermont and Colorado were mainly attributable to increased competition in recreational cannabis stores and a difficult year-over-year comparison, offset by increases in its wholesale channel in Vermont, as well as a decline in the overall cannabis market in Colorado. The Core Market declines were offset by the Company's Emerging Markets, with a notable increase in its e-commerce channel.
  • Gross profit of $3.36 million (48% gross margin) in Q1 2024, compared with $5.72 million (53% gross margin) in Q1 2023, representing a 41% decrease in gross profit and a 5% decrease in gross margin year-over-year. Gross profit before fair value of biological assets was $3.65 million (52% gross margin) in Q1 2024, compared with $5.68 million (52% gross margin) in Q1 2023, representing a 36% decrease in gross profit before fair value of biological assets, while maintaining a stable gross margin before fair value of biological assets of 52% year-over-year.
  • Operating expenses of $5.54 million in Q1 2024, compared with $5.78 million in Q1 2023 and $6.63 million in Q4 2023, representing a 4% decrease year-over-year and 16% decrease quarter-over-quarter. The reduction year-over-year was primarily driven by a decrease in salaries and wages, consulting and subcontractors, general and administrative and insurance. The reduction quarter-over-quarter was primarily driven by a decrease in share-based payments, general and administrative, salaries and wages, professional fees and depreciation and amortization.
  • EBITDA1 of ($1.48 million) in Q1 2024, compared with $0.68 million in Q1 2023. The reduction in EBITDA is primarily attributable to a $2.40 million decrease in gross profit (excluding depreciation costs), offset by a reduction of $0.23 million in operating expenses (excluding depreciation) such as salaries and wages, consulting and subcontractors, general and administrative and insurance.
  • Adjusted EBITDA1 of ($1.06 million) in Q1 2024, compared with $0.74 million in Q1 2023. The reduction in Adjusted EBITDA is primarily attributable to a decrease of $2.07 million in gross profit before fair value adjustments of biological assets (excluding depreciation costs), offset by a reduction of $0.27 million in operating expenses (excluding depreciation expenses, expected credit losses and share based payments).
  • $8.32 million in cash and restricted cash on March 31, 2024, compared to $9.04 million on December 31, 2023. Additionally, for the three months ended March 31, 2024, cash flows used in operating activities was ($0.48 million), compared to cash flows from operating activities of $0.37 million for the three months ended March 31, 2023, a reduction of $0.85 million.
  • 2024年3月31日结束的三个月营业收入为703万加元。佛蒙特州和科罗拉多州SLANG的核心市场的下降主要归因于娱乐大麻店的竞争加剧和难以比较的同比,这些都得到了在佛蒙特州的批发渠道增长、以及科罗拉多州整体大麻市场下降的抵消。本公司新兴市场,尤其是其电子商务渠道的销售增长明显,为核心市场的下降提供了抵消。
  • 2024年第一季度,毛利润为336万加元(48%毛利率),而2013年第一季度毛利润为572万加元(53%毛利率),毛利润同比下降了41%,毛利率同比下降了5%。在生物资产公允价值之前的毛利润为365万加元(毛利率52%),而2013年第一季度毛利润为568万加元(毛利率52%),毛利润毛利率保持稳定,同比下降了36%。
  • 2024年第1季度的营业费用为554万加元,而2013年第1季度的营业费用为578万加元,2013年第4季度的营业费用为663万加元,同比下降了4%,环比下降了16%。年复合降低主要是由于薪资和工资、咨询和分包商、一般和管理和保险费用的降低。环比降低主要是由于股票基础支付、一般和管理、工资和薪金、专业费用、以及折旧和摊销的降低。
  • EBITDA12024年第1季度EBITDA为-148万加元,而2013年第1季度为68万加元。EBITDA的降低主要归因于毛利润的343万加元下降(不包括折旧费用),而各区间营业费用减少了230万加元(不包括折旧费用、预期信用损失和股票基础支付),例如工资和工资、咨询和分包商、一般和管理和保险。
  • 调整后的EBITDA12024年第1季度调整后EBITDA为-106万加元,而2013年第1季度为74万加元。调整后EBITDA的降低主要归因于生物资产公允价值调整前的毛利润下降了207万加元(不包括折旧成本),而不包括折旧成本、预计信用损失和基于股票的支付的营业费用减少了27万加元。
  • 2024年3月31日,现金和限制性现金为832万加元,而2023年12月31日为904万加元。此外,在2024年3月31日前三个月,经营活动中使用的现金为480万加元,而2013年3月31日前三个月的经营活动现金流量为370万加元,下降了850万加元。

First Quarter 2024 Operational Highlights

2024年第一季度运营业绩亮点

  • Vermont Q1 2024 wholesale sales were $0.31 million, compared to $0.06 million in Q1 2023.
  • During Q1 2024, the Company signed an agreement with a new distribution partner to sell its Alchemy Naturals CBD gummies throughout the United States.
  • SLANG continues to see growth in its Alchemy Naturals CBD gummies, which contributed $0.46 million in e-commerce sales in Q1 2024 compared to $0.30 million in Q4 2023, representing 53% growth quarter-over-quarter.
  • 佛蒙特州2024年第一季度的批发销售额为310,000加元,而2013年第一季度为60,000加元。
  • 在2024年第1季度,公司与新的分销合作伙伴签订了协议,销售其Alchemy Naturals CBD蜜饯,在美国全国范围内销售。
  • SLANG继续看好其Alchemy Naturals CBD蜜饯的增长,这款商品在2024年第1季度为电子商务销售贡献了460,000加元,而2013年第4季度为300,000加元,同比增长了53%。

First Quarter 2024 Financial Review

2024年第1季度财务回顾

The consolidated financial statements were prepared in accordance with IFRS. The following is a selected presentation of the Income Statement for the three months ended March 31, 2024.

财务报表是根据国际财务报告准则(IFRS)编制的。下面是2024年3月31日结束的三个月的收入报表的精选报表。

(In thousands of Canadian dollars except per share data and percentages) For the three months ended
31-Mar-24 31-Mar-23
Net Operating Revenue 7,029 10,823
Cost of goods sold 3,379 5,141
Gross Profit Before Fair Value Adjustment of Biological Assets 3,650 5,682
Realized fair value amounts included in inventory sold (580)
(423)
Unrealized gain on changes in fair value of biological assets 292 457
Gross Profit 3,362 5,716
Gross Profit Margin 48% 53%
Operating expenses 5,542 5,778
Operating Loss (2,180)
(62)
Other items (FV adjustment, FX, gains/losses, taxes, etc.) (3,842)
(2,267)
Total Comprehensive Loss (6,022)
(2,329)
Earnings Per Share
Basic (0.03)
(0.02)
Diluted (0.03)
(0.02)
(以加拿大元为单位.仅除每股数据和百分比.) 截至2023年1月31日三个月的
2024年3月31日 2023年3月31日
净营业收入 7,029 10,823
营业成本 3,379 5,141
公允价值调整之前的毛利润 3,650 5,682
已实现公允价值金额包括销售库存 (580)
(423)
未实现生物资产公允价值变动收益 292 457
毛利润 3,362 5,716
毛利率 48% 53%
营业费用 5,542 5,778
营业亏损 (2,180)
(62)
其他项目(公允价值调整、外汇、收益/损失、税项等) (3,842)
(2,267)
综合损失总额 (6,022)
(2,329)
每股收益
基本 (0.03)
(0.02)
摊薄 (0.03)
(0.02)
(In thousands of Canadian dollars except percentages) For the three months ended
31-Mar-24 31-Mar-23
Net Operating Revenue 7,029 10,823
Cost of Goods Sold 3,379 5,141
Realized fair value amounts included in inventory sold (580)
(423)
Unrealized gain on fair value of biological assets 292 457
Cost of Goods Sold 3,667 5,107
Gross Profit 3,362 5,716
Gross Profit Margin 48% 53%
Gross Profit before FV adjustment 3,650 5,682
Gross Profit Margin before FV adjustment 52% 52%
(以加元为单位,除百分比外) 截至2023年1月31日三个月的
2024年3月31日 2023年3月31日
净营业收入 7,029 10,823
营业成本 3,379 5,141
已实现公允价值金额包括销售库存 (580)
(423)
未实现生物资产公允价值收益 292 457
营业成本 3,667 5,107
毛利润 3,362 5,716
毛利润率 48% 53%
公允价值调整前毛利润 3,650 5,682
公允价值调整前毛利润率 52% 52%
(In thousands of Canadian dollars) For the three months ended
31-Mar-24 31-Mar-23
Total Comprehensive Loss (6,022)
(2,329)
EBITDA (Non-IFRS) (1,482)
679
Adjusted EBITDA (Non-IFRS) (1,064)
742
(以千加元计) 截至2023年1月31日三个月的
2024年3月31日 2023年3月31日
综合损失总额 (6,022)
(2,329)
EBITDA (非IFRS) (1,482)
679
调整后的EBITDA(非IFRS) (1,064)
742

See the Company's management's discussion and analysis for the three months ended March 31, 2024 (the "Q1 2024 MD&A"), for a detailed reconciliation of EBITDA and Adjusted EBITDA to Operating Income / (Loss). SLANG's financial statements and the Q1 2024 MD&A are available on SEDAR+ at , and on the Company's Investor Relations website at .

有关EBITDA和调整后的EBITDA与营业收入/(亏损)的详细账户和分析,请参阅公司管理层讨论和分析截至2024年3月31日的三个月(“Q1 2024 MD&A”) 。 SLANG的财务报表和Q1 2024 MD&A可在SEDA+上获得,并可在公司的投资者关系网站上获取。

Non-IFRS Measures

中期简明合并资产负债表

EBITDA and Adjusted EBITDA are non-IFRS financial measures that the Company uses to assess its operating performance. EBITDA is defined as net earnings (loss) before net finance costs, income tax expense (benefit) and depreciation and amortization expense. Management defines Adjusted EBITDA as EBITDA adjusted for other non-cash items such as the impact of unrealized fair values, share based compensation expense, impairments, one-time gains and losses, and one-time revenues and expenses. This data is furnished to provide additional information and are non-IFRS measures and do not have any standardized meaning prescribed by IFRS. The Company uses these non-IFRS measures to provide shareholders and others with supplemental measures of its operating performance. The Company also believes that securities analysts, investors and other interested parties, frequently use these non-IFRS measures in the evaluation of companies, many of which present similar metrics when reporting their results. As other companies may calculate these non-IFRS measures differently than the Company, these metrics may not be comparable to similarly titled measures reported by other companies. We caution readers that Adjusted EBITDA should not be substituted for determining net loss as an indicator of operating results, or as a substitute for cash flows from operating and investing activities.

EBITDA和调整后的EBITDA是公司用于评估其运营业绩的非IFRS财务指标。 EBITDA定义为净收益(损失)减去净财务费用,所得税费用(收益)和折旧和摊销费用。管理层定义调整后的EBITDA为除不实现公平价值、股票补偿费用、减值、一次性收益和损失及一次性收入和费用等非现金项目外的EBITDA。 这些数据是提供额外信息的,是非IFRS财务指标,并且没有IFRS规定的任何标准化含义。公司使用这些非IFRS指标为股东和其他人提供其运营业绩的补充指标。公司还相信,证券分析师、投资者和其他感兴趣的各方在评估公司时经常使用这些非IFRS指标,其中许多公司在报告业绩时呈现类似的指标。由于其他公司可能以与公司不同的方式计算这些非IFRS指标,因此这些指标可能与其他公司报告的同名指标不可比较。 我们提醒读者,不应以调整后的EBITDA替代确定净损失作为运营业绩指标或现金流量作为经营和投资活动的替代。

Conference Call Details

电话会议详情

Management plans to host an investor conference call on May 30, 2024, at 10:00 am ET to discuss the results.

管理层计划于2024年5月30日上午10:00(美东时间)举行投资者电话会议,讨论公司业绩。

Timing: Thursday, May 30, 2024, at 10:00 am ET
Dial In: (888) 440-5983 (US toll-free) or +1 (646) 960-0202 (international)
Conference ID: 6291438
Webcast: A live webcast can be accessed via the Company's website at or

时间:2024年5月30日上午10:00(美东时间)星期四
拨号:(888)440-5983(美国免费)或+1(646)960-0202(国际)
会议ID:6291438
网络直播:可通过公司网站或 访问直播。

About SLANG Worldwide Inc.
SLANG Worldwide Inc. is the industry leader in branded cannabis consumer packaged goods, with a diversified portfolio of five distinct brands and products distributed across the U.S. Operating in 13 legal cannabis markets nationwide, SLANG specializes in acquiring and developing market-proven regional brands, as well as launching innovative new brands to seize global market opportunities and match evolving consumer tastes. The Company has over a decade of experience operating in the nascent and highly regulated cannabis sector, and its partners enjoy the benefits of that experience, with access to the SLANG playbook for successful operations, sales and marketing. Its strong product pipeline from uniquely positioned and scalable brands like O.pen, Alchemy Naturals, Ceres, Firefly, and partnerships with brands like Greenhouse Seed Company have a proven track record of success with the brands consistently ranking among the top performers in the states where SLANG operates. Learn more at slangww.com.

关于SLANG Worldwide Inc.
SLANG Worldwide Inc.是品牌化大麻消费品行业的行业领导者,拥有在美国分布的五个不同品牌和产品的多样化组合。在全国13个合法的大麻市场运营,SLANG专门获取和开发市场已经证明的区域品牌,以及推出创新的新品牌,以抓住全球市场机会和匹配不断变化的消费者口味。公司在新兴且高度监管的大麻板块有十多年的运营经验,其合作伙伴享受该经验的好处,可以获取SLANG的成功运营、销售和营销方案。其来自独特位置和可扩展品牌组合的强大产品动态,如O.pen、Alchemy Naturals、Ceres、Firefly和与Greenhouse Seed Company等品牌的合作伙伴关系,在SLANG运营的州中品牌一直名列前茅。详见slangww.com。

To be added to SLANG's email distribution list, please email SLNG@kcsa.com with "SLNG" in the subject.

如需将SLANG 加入电子邮件分发列表,请致信 SLNG@kcsa.com 并将邮件主题标注为“ SLNG ”。

Forward-Looking Statements

前瞻性声明

This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur.

本新闻稿包含构成“前瞻性声明”的声明。这些前瞻性声明涉及已知和未知的风险、不确定性和其他因素,这些因素可能导致预期的结果、绩效或成就或行业发展与预期的结果、绩效或成就或暗示的结果、绩效或成就存在实质差异。前瞻性声明是不是历史事实,并通常但不总是通过“期望”、“计划”、“预期”、“相信”、“意图”、“估计”、“项目”、“潜在”和类似表达式识别,或者事件或条件“将”、“会”、“可能”、“可能”或“应该”发生。

Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management of SLANG at this time, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that could cause actual results to differ materially from those expressed or implied in such statements. Investors are cautioned not to put undue reliance on forward-looking statements. Applicable risks and uncertainties include, but are not limited to regulatory risks, risks related to changes in laws, resolutions and guidelines, market risks, concentration risks, operating history, competition, the risks associated with international and foreign operations and the other risks identified under the headings "Risk Factors" in SLANG's Q1 2024 MD&A and other disclosure documents available on the Company's profile on SEDAR+ at . SLANG is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

前瞻性声明必须基于一系列估计和假设,尽管此时SLANG管理层认为这些估计和假设是合理的,但它们本质上都受到重大的商业、经济和竞争性风险、不确定性和应急情况的影响,这些风险、不确定性和应急情况可能导致实际结果与在这些声明中表达或暗示的结果存在实质差异。投资者应谨慎地对待前瞻性声明。适用的风险和不确定性包括但不限于监管风险、有关法律、决议和指导方针的风险、市场风险、集中风险、运营历史、竞争、与国际和外国业务相关的风险以及SLANG的Q1 2024 MD&A和公司在SEDA+上的档案中可供阅读的其他披露文件中“风险因素”下识别的其他风险。公司无需并明确否认有任何义务或承诺更新或修订任何前瞻性信息,无论是因为新信息、未来事件还是其他方面,除非适用法律明确要求。

Reader Advisory

读者声明

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

无论是加拿大证券交易所还是证券交易所监管机构(该术语在加拿大证券交易所政策中有定义)都不承担本发布的充分性或准确性的责任。

Company Contact
Mikel Rutherford, CFO
833-752-6499

公司联系 Marcia Novero Innodata Inc. Mnovero@innodata.com (201) 371-8015
Mikel Rutherford,首席财务官
833-752-6499

KCSA Strategic Communications
Phil Carlson
SLANG@kcsa.com

KCSA战略传播
Phil Carlson
SLANG@kcsa.com


1 EBITDA and Adjusted EBITDA are non-IFRS financial measures that is further described under the section "Non-IFRS Measures" herein.

1“非IFRS措施”一节中进一步描述了EBITDA和调整后的EBITDA的非IFRS财务措施。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发